Evonik Industries AG Company Analysis & Research
Evonik Industries AG is a German chemical company offering a mix of specialty and commodity chemical products. The company operates globally across multiple high-growth sectors including nutrition, healthcare, and sustainable materials through four segments: Specialty Additives, Smart Materials, Nutrition & Care, and Technology & Infrastructure.
Aggressive cost-saving initiatives and digital transformation are set to drive lasting margin expansion, with strategic focus on sustainable technologies and resilient production supporting robust earnings growth. However, rising regulatory costs, required environmental upgrades, and green competition threaten margins, while dependence on shrinking European markets limits growth prospects.
Company Overview
Founded: 1847. Headquarters: Essen, Germany. Revenue: $15.7B. Market Cap: $7.5B. Ticker: EVK (XETRA).
Industry
Specialty Chemicals
Cyborg Score: 5/10 — Mixed
Turnaround potential through operational efficiency and sustainability focus, but challenged by margin pressures and earnings decline.
Evonik remains a fundamentally strong specialty chemicals company, now trading at attractive valuations despite recent earnings downgrades. The company faces headwinds from profitability challenges, but cost initiatives and sustainable product focus offer upside potential.
Key Strategic Insights for Evonik Industries AG
- Trailing 12-month revenue of $15.7B as of September 2025
- Dividend yield of 6.25%, supported by long-term dividend history
- Five-year net income decline of 26% indicating profitability headwinds
- Rising regulatory costs and environmental upgrade requirements pressuring margins
Recent Developments
- (February 2026) Mixed analyst sentiment with Kepler Capital maintaining sell rating; Deutsche Bank and Warburg Research holding neutral stance
- (December 2024) Joint venture with Evonik Fuhua New Materials (Sichuan) in China
- (2025) Adjusted financial outlook reflecting market challenges and demand shifts
Competitors & Competitive Landscape
- Wacker Chemie — Specialty chemicals and polymers
- BASF SE — Integrated chemical company
- Lanxess AG — Specialty chemicals
- Clariant — Specialty chemicals and materials
Evonik competes with companies like Wacker Chemie, a Munich-based specialty chemicals producer. As a diversified specialty chemicals company with global reach, Evonik competes across multiple segments including additives, polymers, nutrition ingredients, and pharmaceutical materials. Competition intensifies from low-cost producers and new entrants in sustainable chemistry.
More Company Research
Softstar Entertainment Inc. COG Financial Services Limited RWS Holdings plc Duniec Bros. Ltd PagerDuty, Inc. The Wendy's Company AEON Financial Service Co., Ltd. Hayward Holdings, Inc. The Commercial Bank (P.S.Q.C.) Hoa Phat Group Joint Stock Company American Homes 4 Rent PPL Corporation Synopsys, Inc. Vapotherm, Inc. Cato, Inc.Full Company Research Reports
Looking for a more in-depth analysis of Evonik Industries AG? AskCyborg's Company Research section contains full AI-generated reports with detailed financials, strategic analysis, and Cyborg Score ratings. Browse the complete company research library or explore industry research reports.
AskCyborg provides AI-powered company research and analysis. Visit AskCyborg for full reports, Cyborg Score ratings, analyst debate audio, and saved-company audio playlists.